| Literature DB >> 30583738 |
Federica Bernardini1, Roya Elaine Haghighat-Khah1, Roberto Galizi1, Andrew Marc Hammond1, Tony Nolan1, Andrea Crisanti2.
Abstract
Malaria is a serious global health burden, affecting more than 200 million people each year in over 90 countries, predominantly in Africa, Asia and the Americas. Since the year 2000, a concerted effort to combat malaria has reduced its incidence by more than 40%, primarily due to the use of insecticide-treated bednets, indoor residual spraying and artemisinin-based combination drug therapies. Nevertheless, the cost of control is expected to nearly triple over the next decade and the current downward trend in disease transmission is threatened by the rise of resistance to drugs and insecticides. Novel strategies that are sustainable and cost-effective are needed to help usher in an era of malaria elimination. The most effective strategies thus far have focussed on control of the mosquito vector. The sterile insect technique (SIT) is a potentially powerful strategy that aims to suppress mosquito populations through the unproductive mating of wild female mosquitoes with sterile males that are released en masse. The technique and its derivatives are currently not appropriate for malaria control because it is difficult to sterilise males without compromising their ability to mate, and because anopheline males cannot be easily separated from females, which if released, could contribute to disease transmission. Advances in genome sequencing technologies and the development of transgenic techniques provide the tools necessary to produce mosquito sexing strains, which promise to improve current malaria-control programs and pave the way for new ones. In this review, the progress made in the development of transgenic sexing strains for the control of Anopheles gambiae, a major vector of human malaria, is discussed.Entities:
Keywords: Anopheles mosquitoes; Malaria; genetic engineering; sex determination; vector control
Mesh:
Substances:
Year: 2018 PMID: 30583738 PMCID: PMC6304780 DOI: 10.1186/s13071-018-3207-8
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Schematic view of site-specific integration of transgenes into the Y chromosome of the Anopheles gambiae Y-attP strain. The Y-attP line carries the attP docking site and a 3xP3-RFP fluorescence marker transcription unit [60]. a The ΦC31 integrase, provided in the form of plasmid, catalyses the recombination reaction between the attP target sequence (orange) and attB donor sequence (blue) resulting in the site-specific integration of the transgenic construct onto the Y chromosome. After recombination, hybrid sites called attL and attR are generated, which are no longer recognised by the integrase thus conferring stability to the integration. b A Cas9 coupled with a gRNA (shown as the molecular scissors) induces a double-strand break (DSB) at the attP target site. A donor plasmid containing homologous regions upstream and downstream of the DSB site acts as a template for homology-directed repair. This results in the insertion of the transgenes of interest into the Y chromosome (Table 1; Haghighat-Khah RE et al., unpublished)
Comparison of integrase-based and nuclease-based approaches to engineer the Y-chromosome of Anopheles gambiae
| Donor plasmid | Helper Plasmid | Injected G0 embryos | Surviving G0 larvae | Transient G0 Larvae | Transient G0 adult ♂ | Pooled cages | Transgenic G1s |
|---|---|---|---|---|---|---|---|
| A | |||||||
| 33 nM pHomeT | 35 nM | 1769 | 134 | 44 | 29 | 5 | 16/6559 |
| ϕC31 integrase | 1 pooled G0 transient cage | ||||||
| 33 nM pHomeT | 35 nM | 600 | 127 | 68 | 29 | 6 | 63/5147 |
| 3 pooled G0 transient cages | |||||||
| B | |||||||
| 40 nM attBCFP-VasaGFP | 96 nM | ~2000 | n/a | n/a | 5 | n/a | 6/791 |
| ϕC31 integrase | |||||||
| 52 nM 3xP3[AttP]RFP | 90 nM | ~4000 | n/a | n/a | 15 | n/a | 11/6160 |
| I-SceI | |||||||
(A) ΦC31-att recombinase was used to insert a vector, pHomeT, containing the attB donor sequence into the Y-attP strain, carrying the complementary attP target sequence on the Y-chromosome. CRISPR-cas9-directed knock-in was used to integrate the pHomeT plasmid into the same Y locus. (B) ΦC31-att recombinase was used to integrate a vector, attBCFPVasaGFP, containing the attB donor sequence into the Y-attP strain. I-SceI-directed knock-in was used to integrate the vector 3xP3[AttP]RFP into the Y chromosome of T4 strain, carrying the I-SceI recognition site [60].